Discovering new drugs is both our profession and our passion.
Ecrins Therapeutics is a privately held biotech company specialized in the discovery and development of innovative oncology drugs for human and veterinary applications.
Discover our work and our team through this website
Backed by our skills and knowledge in this field, our commercial division, “Ecrins Therapeutics Products and Services”, aims to share our unique expertise in cytoskeleton characterisation with fellow scientists. To discover what we can do for you, please visit the Product & Services page and the dedicated website. We are certified “Research Tax Credit” (CIR- “Crédit d’Impôt Recherche”) for 2015-19 (see news).